vs
Side-by-side financial comparison of ASTRONICS CORP (ATRO) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
ASTRONICS CORP is the larger business by last-quarter revenue ($240.1M vs $185.2M, roughly 1.3× AMICUS THERAPEUTICS, INC.). On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 15.1%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $15.8M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 13.9%).
Astronics Corporation is an American aerospace electronics corporation founded in 1968, headquartered in East Aurora, New York. It is traded on NASDAQ as Nasdaq: ATRO. It is known for lighting and electronics integrations on military, commercial, and business aircraft and semiconductor test systems.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
ATRO vs FOLD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $240.1M | $185.2M |
| Net Profit | — | $1.7M |
| Gross Margin | 33.3% | 85.7% |
| Operating Margin | 14.8% | 8.6% |
| Net Margin | — | 0.9% |
| Revenue YoY | 15.1% | 23.7% |
| Net Profit YoY | — | -88.5% |
| EPS (diluted) | $0.82 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $240.1M | $185.2M | ||
| Q3 25 | $211.4M | $169.1M | ||
| Q2 25 | $204.7M | $154.7M | ||
| Q1 25 | $205.9M | $125.2M | ||
| Q4 24 | $208.5M | $149.7M | ||
| Q3 24 | $203.7M | $141.5M | ||
| Q2 24 | $198.1M | $126.7M | ||
| Q1 24 | $185.1M | $110.4M |
| Q4 25 | — | $1.7M | ||
| Q3 25 | $-11.1M | $17.3M | ||
| Q2 25 | $1.3M | $-24.4M | ||
| Q1 25 | $9.5M | $-21.7M | ||
| Q4 24 | — | $14.7M | ||
| Q3 24 | $-11.7M | $-6.7M | ||
| Q2 24 | $1.5M | $-15.7M | ||
| Q1 24 | $-3.2M | $-48.4M |
| Q4 25 | 33.3% | 85.7% | ||
| Q3 25 | 30.5% | 88.5% | ||
| Q2 25 | 25.8% | 90.2% | ||
| Q1 25 | 29.5% | 90.7% | ||
| Q4 24 | 29.8% | 90.1% | ||
| Q3 24 | 27.1% | 90.6% | ||
| Q2 24 | 28.0% | 91.1% | ||
| Q1 24 | 25.7% | 87.7% |
| Q4 25 | 14.8% | 8.6% | ||
| Q3 25 | 10.9% | 20.3% | ||
| Q2 25 | 2.3% | -6.1% | ||
| Q1 25 | 6.4% | -6.3% | ||
| Q4 24 | 4.3% | 10.7% | ||
| Q3 24 | 4.1% | 15.3% | ||
| Q2 24 | 3.8% | 11.8% | ||
| Q1 24 | 0.9% | -25.1% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | -5.2% | 10.2% | ||
| Q2 25 | 0.6% | -15.8% | ||
| Q1 25 | 4.6% | -17.3% | ||
| Q4 24 | — | 9.8% | ||
| Q3 24 | -5.8% | -4.8% | ||
| Q2 24 | 0.8% | -12.4% | ||
| Q1 24 | -1.7% | -43.9% |
| Q4 25 | $0.82 | $0.00 | ||
| Q3 25 | $-0.31 | $0.06 | ||
| Q2 25 | $0.04 | $-0.08 | ||
| Q1 25 | $0.26 | $-0.07 | ||
| Q4 24 | $-0.07 | $0.05 | ||
| Q3 24 | $-0.34 | $-0.02 | ||
| Q2 24 | $0.04 | $-0.05 | ||
| Q1 24 | $-0.09 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.2M | $293.5M |
| Total DebtLower is stronger | — | $392.7M |
| Stockholders' EquityBook value | $140.1M | $274.2M |
| Total Assets | $706.7M | $949.9M |
| Debt / EquityLower = less leverage | — | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $293.5M | ||
| Q3 25 | $13.5M | $263.8M | ||
| Q2 25 | $13.5M | $231.0M | ||
| Q1 25 | $24.8M | $250.6M | ||
| Q4 24 | $9.3M | $249.9M | ||
| Q3 24 | $5.2M | $249.8M | ||
| Q2 24 | $2.9M | $260.1M | ||
| Q1 24 | $5.3M | $239.6M |
| Q4 25 | — | $392.7M | ||
| Q3 25 | — | $392.0M | ||
| Q2 25 | — | $391.3M | ||
| Q1 25 | — | $390.7M | ||
| Q4 24 | — | $390.1M | ||
| Q3 24 | — | $389.5M | ||
| Q2 24 | — | $388.9M | ||
| Q1 24 | — | $388.4M |
| Q4 25 | $140.1M | $274.2M | ||
| Q3 25 | $108.9M | $230.4M | ||
| Q2 25 | $271.6M | $204.3M | ||
| Q1 25 | $266.8M | $193.6M | ||
| Q4 24 | $256.1M | $194.0M | ||
| Q3 24 | $249.2M | $178.8M | ||
| Q2 24 | $257.9M | $132.5M | ||
| Q1 24 | $251.7M | $130.7M |
| Q4 25 | $706.7M | $949.9M | ||
| Q3 25 | $682.2M | $868.8M | ||
| Q2 25 | $646.7M | $815.3M | ||
| Q1 25 | $662.2M | $789.8M | ||
| Q4 24 | $648.8M | $785.0M | ||
| Q3 24 | $651.6M | $786.6M | ||
| Q2 24 | $644.9M | $749.5M | ||
| Q1 24 | $630.0M | $721.8M |
| Q4 25 | — | 1.43× | ||
| Q3 25 | — | 1.70× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.02× | ||
| Q4 24 | — | 2.01× | ||
| Q3 24 | — | 2.18× | ||
| Q2 24 | — | 2.93× | ||
| Q1 24 | — | 2.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $27.6M | $16.3M |
| Free Cash FlowOCF − Capex | $15.8M | $16.0M |
| FCF MarginFCF / Revenue | 6.6% | 8.6% |
| Capex IntensityCapex / Revenue | 4.9% | 0.2% |
| Cash ConversionOCF / Net Profit | — | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | $43.1M | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $27.6M | $16.3M | ||
| Q3 25 | $34.2M | $35.7M | ||
| Q2 25 | $-7.6M | $-26.5M | ||
| Q1 25 | $20.6M | $7.8M | ||
| Q4 24 | $26.4M | $-3.9M | ||
| Q3 24 | $8.4M | $-23.0M | ||
| Q2 24 | $-6.3M | $22.7M | ||
| Q1 24 | $2.0M | $-29.7M |
| Q4 25 | $15.8M | $16.0M | ||
| Q3 25 | $21.0M | $35.3M | ||
| Q2 25 | $-12.2M | $-28.9M | ||
| Q1 25 | $18.5M | $7.5M | ||
| Q4 24 | $23.2M | $-4.2M | ||
| Q3 24 | $6.5M | $-23.3M | ||
| Q2 24 | $-8.1M | $21.6M | ||
| Q1 24 | $439.0K | $-31.5M |
| Q4 25 | 6.6% | 8.6% | ||
| Q3 25 | 9.9% | 20.9% | ||
| Q2 25 | -6.0% | -18.7% | ||
| Q1 25 | 9.0% | 6.0% | ||
| Q4 24 | 11.1% | -2.8% | ||
| Q3 24 | 3.2% | -16.5% | ||
| Q2 24 | -4.1% | 17.0% | ||
| Q1 24 | 0.2% | -28.5% |
| Q4 25 | 4.9% | 0.2% | ||
| Q3 25 | 6.2% | 0.2% | ||
| Q2 25 | 2.2% | 1.6% | ||
| Q1 25 | 1.0% | 0.2% | ||
| Q4 24 | 1.5% | 0.2% | ||
| Q3 24 | 0.9% | 0.3% | ||
| Q2 24 | 0.9% | 0.9% | ||
| Q1 24 | 0.9% | 1.6% |
| Q4 25 | — | 9.62× | ||
| Q3 25 | — | 2.06× | ||
| Q2 25 | -5.81× | — | ||
| Q1 25 | 2.17× | — | ||
| Q4 24 | — | -0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | -4.08× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATRO
| Product Line Electrical Power And Motion | $113.8M | 47% |
| Product Line Avionics | $32.0M | 13% |
| Military Aircraft | $28.0M | 12% |
| General Aviation | $22.3M | 9% |
| Government And Defense | $20.5M | 9% |
| Product Line Systems Certification | $13.2M | 6% |
| Product Line Structures | $3.7M | 2% |
| Product Line Other | $2.3M | 1% |
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
